Evaluation status available after sign-in
About the journal
JTO Clinical and Research Reports is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,000 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-3643
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,000 USD
- Articles in DOAJ
- 842
- Declared review time
- 19 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2021-02-26
- Indexing
- DOAJ
- APC
- 2,000 USD
- Declared review time (DOAJ)
- 19 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
842
Most recent article
last month
Average review time (journal-declared via DOAJ)
19weeks
Works in OpenAlex
859
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
33
i10-index
197
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-01-13
- Added to DOAJ
- 2021-02-26
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 90%
- ORCID iDs in current deposits
- 60%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Journal of Thoracic Oncology clinical and research reports
- Source type
- journal
- NLM unique ID (PubMed)
- 101769967
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Show all subjects (75)
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Occupational and environmental lung diseases
- Metastasis and carcinoma case studies
- Radiomics and Machine Learning in Medical Imaging
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Radiomics and Machine Learning in Medical Imaging
- Global Cancer Incidence and Screening
- Brain Metastases and Treatment
- Myasthenia Gravis and Thymoma
- Myasthenia Gravis and Thymoma
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Occupational and environmental lung diseases
- Brain Metastases and Treatment
- Occupational and environmental lung diseases
- Neuroendocrine Tumor Research Advances
- Brain Metastases and Treatment
- Neuroendocrine Tumor Research Advances
- Melanoma and MAPK Pathways
- Myasthenia Gravis and Thymoma
- Intraperitoneal and Appendiceal Malignancies
- Melanoma and MAPK Pathways
- Colorectal and Anal Carcinomas
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Colorectal and Anal Carcinomas
- Cancer survivorship and care
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pleural and Pulmonary Diseases
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Chronic Lymphocytic Leukemia Research
- Genetic factors in colorectal cancer
- Chronic Lymphocytic Leukemia Research
- Genetic factors in colorectal cancer
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Health Systems, Economic Evaluations, Quality of Life
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Cardiac tumors and thrombi
- Advanced Radiotherapy Techniques
- Head and Neck Cancer Studies
- Medical Imaging and Pathology Studies
- COVID-19 and healthcare impacts
- Colorectal Cancer Treatments and Studies
- Cancer Mechanisms and Therapy
- Neuroendocrine Tumor Research Advances
- Smoking Behavior and Cessation
- Radiomics and Machine Learning in Medical Imaging
- Pleural and Pulmonary Diseases
Keywords (DOAJ)
- lung cancer
- thoracic oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ